PubRank

Gavin Churchyard

Author PubWeight™ 30.70‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med 2009 5.78
2 Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study. Lancet Infect Dis 2011 3.71
3 Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease. PLoS Med 2007 2.88
4 Epidemiology of HIV-associated tuberculosis. Curr Opin HIV AIDS 2009 2.86
5 The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J 2013 2.80
6 Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet 2010 1.69
7 Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa. Antivir Ther 2009 1.66
8 Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa. BMC Infect Dis 2013 1.20
9 Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization. J Virol 2010 1.18
10 Outcomes following virological failure and predictors of switching to second-line antiretroviral therapy in a South African treatment program. J Acquir Immune Defic Syndr 2012 1.13
11 Second-line antiretroviral therapy in a workplace and community-based treatment programme in South Africa: determinants of virological outcome. PLoS One 2012 1.13
12 Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch. J Infect Dis 2013 1.09
13 Expanding HIV care in Africa: making men matter in Johannesburg. Lancet 2009 0.99
14 What is thwarting tuberculosis prevention in high-burden settings? N Engl J Med 2011 0.93
15 Diagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas. J Infect Dis 2011 0.87
16 Isoniazid preventive therapy for HIV-infected people: evidence to support implementation. AIDS 2010 0.85
17 'Team up against TB': promoting involvement in Thibela TB, a trial of community-wide tuberculosis preventive therapy. AIDS 2010 0.80